000 01422 a2200421 4500
005 20250516023707.0
264 0 _c20110705
008 201107s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2011.01.093
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHudson, Andrew R
245 0 0 _aDiscovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonists.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cMar 2011
300 _a1697-700 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aDrug Discovery
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHumans
650 0 4 _aQuinolines
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Glucocorticoid
_xagonists
650 0 4 _aStructure-Activity Relationship
700 1 _aHiguchi, Robert I
700 1 _aRoach, Steven L
700 1 _aAdams, Mark E
700 1 _aVassar, Angela
700 1 _aSyka, Peter M
700 1 _aMais, Dale E
700 1 _aMiner, Jeffrey N
700 1 _aMarschke, Keith B
700 1 _aZhi, Lin
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 21
_gno. 6
_gp. 1697-700
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2011.01.093
_zAvailable from publisher's website
999 _c20594427
_d20594427